Nadine Houede, Thierry Chevallier, Jaffrelot Loic, Constance Thibault, Neuzillet Yann, Christine Abraham Jaillon, Alexandra Masson-Lecomte, Gwenaelle Gravis, Sophie Tartas, Damien Pouessel, Brigitte Laguerre, François Audenet, Evanguelos Xylinas, Luquiens Guillaume, Morgan Roupret. "Safety and efficacy of neoadjuvant immunotherapy with durvalumab (MEDI 4736) in combination with neoadjuvant chemotherapy (gemcitabine/cisplatin or carboplatin) in patients with operable high-risk upper tract urothelial carcinoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.661